Orion develops innovative, new, more effective, safer and more cost-efficient drugs and diagnostic tests for healthcare needs. Every employee involved in Orion’s R&D activities is requested to obey the regulatory standards and ethical principles of pharmaceutical R&D.

Orion conducts R&D activity in conformity with the Helsinki Declaration concerning the ethical principles applicable to human medicinal research as well as Good Clinical and Laboratory Practices. The study designs and research protocols are evaluated and approved in accordance with the legal requirements. Data from clinical studies is recorded, handled and saved confidentially and in a manner allowing correct and transparent reporting and disclosure of the study results. The results are published in a truthful manner.

Studies involving animal experiments shall be carefully considered and motivated. Laboratory animals shall be treated with the best possible care, and they shall only be used if no alternative testing method is available. So-called 3R Principles (replacement, reduction, refinement) are applied to animal testing.